Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000129

Chairperson & CEO sold 9,500 shares at an average $517.28 ($4,914,190)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-26 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-08-26 Sale : show line 2 in the form 10b5-1 −559 $514.64 $287,682 333,384 I
2026-08-26 Sale : show line 3 in the form 10b5-1 −1,591 $515.41 $820,010 331,793 I
2026-08-26 Sale : show line 4 in the form 10b5-1 −1,128 $516.70 $582,832 330,665 I
2026-08-26 Sale : show line 5 in the form 10b5-1 −3,516 $517.49 $1,819,503 327,149 I
2026-08-26 Sale : show line 6 in the form 10b5-1 −1,790 $518.35 $927,846 325,359 I
2026-08-26 Sale : show line 7 in the form 10b5-1 −476 $519.35 $247,211 324,883 I
2026-08-26 Sale : show line 8 in the form 10b5-1 −400 $520.62 $208,247 324,483 I
2026-08-26 Sale : show line 9 in the form 10b5-1 −40 $521.48 $20,859 324,443 I
Open-market sales · 9,500 sh · avg $517.28 · $4,914,190

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-26 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −9,500 56,410 I
Loading xslF345X06/primarydocument.xml…